Pre-clinical Safety Assessment of Pharmaceutical Lead Candidates

26
Jan, 2015

Pre-clinical Safety Assessment of Pharmaceutical Lead Candidates

In early drug development, identifying predictable safety issues of pharmaceutical lead candidates is crucial for reducing safety-related attrition later in the process. Approximately 75% of all adverse drug reactions (ADR) have been dose-dependent, which can be predicted on the basis of pharmacology profiling and safety evaluation studies. In this post, we will focus on the […]